Evelyn Partners Investment Management Services Ltd Trims Stake in UnitedHealth Group Incorporated $UNH

Evelyn Partners Investment Management Services Ltd decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 53.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 15,158 shares of the healthcare conglomerate’s stock after selling 17,561 shares during the period. Evelyn Partners Investment Management Services Ltd’s holdings in UnitedHealth Group were worth $4,729,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of UNH. HHM Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after acquiring an additional 26 shares during the period. Hemington Wealth Management lifted its position in shares of UnitedHealth Group by 2.5% during the first quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after buying an additional 28 shares during the last quarter. Tlwm grew its position in shares of UnitedHealth Group by 1.0% in the 1st quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after buying an additional 28 shares during the last quarter. Evermay Wealth Management LLC boosted its stake in UnitedHealth Group by 1.2% in the first quarter. Evermay Wealth Management LLC now owns 2,413 shares of the healthcare conglomerate’s stock valued at $1,264,000 after acquiring an additional 29 shares in the last quarter. Finally, MGO One Seven LLC increased its position in shares of UnitedHealth Group by 0.3% during the first quarter. MGO One Seven LLC now owns 8,781 shares of the healthcare conglomerate’s stock worth $4,599,000 after purchasing an additional 30 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 2.5%

UnitedHealth Group stock opened at $319.40 on Friday. The stock has a market capitalization of $289.32 billion, a PE ratio of 16.67, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The business has a 50 day simple moving average of $344.69 and a 200-day simple moving average of $316.94. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same period last year, the firm posted $7.15 earnings per share. The company’s revenue was up 12.2% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. UnitedHealth Group’s payout ratio is presently 46.14%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research analyst reports. UBS Group increased their price target on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. The Goldman Sachs Group initiated coverage on UnitedHealth Group in a research note on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price objective for the company. Truist Financial raised their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Finally, JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.